Evidence map›Paper›PMID 38302808›Full record

ArticleIntensive care medicine experimental2024

Validation of a low-cost continuous renal replacement therapy dialysate fluid controller for experimental purposes.

Yuri de Albuquerque Pessoa Dos Santos, Viviane Flor Park, Luis Carlos Maia Cardozo Junior, Bruno Adler Maccagnan Pinheiro Besen, Pedro Vitale Mendes, Marcelo Park

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Intensive care medicine experimental, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuri de Albuquerque Pessoa Dos SantosIntensive Care Unit, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, SP, Brazil.
Viviane Flor ParkInstitute of Science and Technology, Federal University of São Paulo, São José dos Campos, SP, Brazil.
Luis Carlos Maia Cardozo JuniorIntensive Care Unit, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, SP, Brazil.
Bruno Adler Maccagnan Pinheiro BesenIntensive Care Unit, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, SP, Brazil.
Pedro Vitale MendesIntensive Care Unit, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, SP, Brazil.
Marcelo ParkIntensive Care Unit, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, SP, Brazil. marcelo.park@hc.fm.usp.br.ORCID http://orcid.org/0000-0002-4201-2718

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundContinuous renal replacement therapy (CRRT) support is crucial for critically ill patients and it is underexplored in specific situations. Experimental CRRT offers a means to gain insights into these scenarios, but the prohibitive cost of CRRT machines limits their accessibility. This study aimed to develop and validate a low-cost and precise dialysate controller for experimental CRRT.

resultsOur results demonstrate a commendable level of precision in affluent flow control, with a robust correlation (R

conclusionsThe low-cost dialysate controller developed and tested in this study offers a precise means of regulating CRRT in experimental settings. Its affordability and accuracy render it a valuable instrument for studying CRRT support in unconventional clinical scenarios, particularly in middle-income countries' experimental ICU laboratories.

Indexed as

Acute kidney injuryContinuous renal replacement therapyCost analysisExperimental dialysisIntensive care units

Identifiers

PMID38302808
PMCPMC10834914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.